AlphaCrest Capital Management LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$748,000
-1.8%
26,458
-23.0%
0.05%
+24.3%
Q2 2022$762,000
+24.9%
34,365
+64.0%
0.04%
+8.8%
Q1 2022$610,000
-35.9%
20,954
-27.6%
0.03%
-2.9%
Q4 2021$951,000
+23.2%
28,931
+73.0%
0.04%
-12.5%
Q3 2021$772,000
-15.6%
16,724
+0.8%
0.04%
+2.6%
Q2 2021$915,000
+286.1%
16,597
+204.0%
0.04%
+95.0%
Q4 2020$237,000
-49.1%
5,460
-58.9%
0.02%
-60.8%
Q3 2020$466,000
+31.6%
13,300
+101.0%
0.05%
-13.6%
Q2 2020$354,000
+26.4%
6,617
+12.8%
0.06%
+156.5%
Q4 2019$280,000
-67.9%
5,865
-66.5%
0.02%
-69.7%
Q2 2019$873,00017,5100.08%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders